Jeff George

Board Director at 908 Devices in February 2021 to Present

Board Director at Amneal Pharmaceuticals in December 2019 to Present

Managing Partner at Maytal Capital in January 2017 to Present

Partner at Bridge Builders Collaborative in August 2021 to April 2025

Chairman at Lykos Therapeutics in May 2020 to January 2025

Board Director at WishBone Medical, Inc. in August 2020 to July 2022

Board Director at Roam Analytics in June 2017 to October 2020

CEO, Performance Health at Performance Health in February 2018 to December 2018

CEO & Division Head, Alcon; Novartis Group Executive Committee member at Novartis in January 2014 to January 2016

CEO & Division Head, Sandoz; Novartis Group Executive Committee member at Novartis in January 2008 to January 2014

Region Head, Emerging Markets (Middle East, Africa, Southeast Asia & CIS), Novartis Pharmaceuticals at Novartis in January 2008 to January 2008

Vice President and Head of Commercial Operations, Western & Eastern Europe, Novartis Vaccines at Novartis in January 2007 to January 2008

Senior Director, Strategy & Business Development, Banana Republic at Gap in January 2004 to January 2006

Engagement Manager at McKinsey & Company in January 2001 to January 2004

Summer Associate, Private Equity at Brait Capital in January 1999 to January 1999

Summer Associate, Private Equity at Overseas Private Investment Corporation in January 1998 to January 1998

Business Analyst at Deloitte in January 1996 to January 1997